Biond Biologics
Blood & Organ Banks · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Misgave Industrial Park, Tel Aviv, Israe...Phone Number
+972 48844337Website
www.biondbio.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
1
1
2
2
About Biond Biologics
Biond Biologics is an innovative biotech company focused on developing breakthrough therapies for cancer treatment. They specialize in novel immuno-oncology solutions and shedding-blocker technologies that enhance immune function and target immune evasion mechanisms. Their product pipeline includes first-in-class biologics and a transformative intracellular delivery platform for biologics. Biond aims to provide life-changing therapies for cancer patients through pioneering scientific research.Explore more
Biond Biologics Org Chart
Get the full picture
Sign in to uncover key details.
SH
Vice President, RA & CMC
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biond Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Biond Biologics is spiking on competitors!
Biond Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Biond Biologics has new funding data
Earning: See what the market has to say on Biond Biologics recently announced quarterly report
Click to see if Biond Biologics had a recent Job posting/layoffs
Check if Biond Biologics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Biond Biologics
Product Launch: Get notified when Biond Biologics launches new products
Recommended Actions
Reach out to Masked Content who joined Biond Biologics as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Biond Biologics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Biond Biologics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Biond Biologics.
Biond Biologics financials insights
Gather financial insights about Biond Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series B
$17M
Series A
$40M
2026
Other Financing Round
$8M
Biond Biologics Tech Stack
A closer look at the technologies used by Biond Biologics
See more technologies
Biond Biologics News & Media
Biond Biologics and Guangzhou-Israel Biotechnology Fund ("GIBF") Announce Closing of $8 Million Investment and Collaboration
Biond Biologics and Guangzhou-Israel Biotechnology Fund (GIBF) Announce Strategic Investment and Joint Venture to Advance First-in-Class Oncology Programs in China MISGAV, Israel and GUANGZHOU, China, June 1, 2026 /PRNewswire/ -- Biond Biologics Ltd., a private clinical-stage...Biond Biologics to Regain Full Rights to BND-22, a Novel Immune Checkpoint Inhibitor Targeting the ILT2 Receptor
Following positive results from the Phase 1 dose escalation study, BND-22 (SAR444881) is now being tested in Phase 2 trials as monotherapy for patients with cholangiocarcinoma and in combination with cetuximab in patients with non-small cell lung cancer (NSCLC) and colorectal cancer (CRC)....Biond Biologics Announces Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany to Evaluate BND-35 in Combination with Cetuximab in a Phase 1 Clinical Study in Patients with Solid Tumors
MISGAV, Israel, Oct. 29, 2024 /PRNewswire/ -- Biond Biologics Ltd. ("Biond" or the "Company"), is a private clinical-stage biopharmaceutical company focusing on novel immunotherapies for cancer and innovative platforms for the intracellular delivery of biologics. Biond is pleased to...Biond Biologics Announces First Patient Dosed with BND-35 in Phase 1 Clinical Trial
BND-35 is a Novel and Unique Anti-ILT3/LILRB4 Antibody for Remodeling the Tumor Microenvironment BND-35-001 trial includes unique combination arms with anti-EGFR (cetuximab) and anti-PD-1/PD-L1, in selected indications MISGAV, Israel, June 24, 2024 /PRNewswire/ -- Biond Biologics Ltd....
Read more news
Top Blood & Organ Banks Companies
See more top companies
Frequently Asked Questions Regarding Biond Biologics
Sign Up For FreeTo access detailed company insights
Biond Biologics is an innovative biotech company focused on developing breakthrough therapies for cancer treatment. They specialize in novel immuno-oncology solutions and shedding-blocker technologies that enhance immune function and target immune evasion mechanisms. Their product pipeline includes first-in-class biologics and a transformative intr... Read More
